Provided By GlobeNewswire
Last update: Apr 3, 2025
SASKATOON, Saskatchewan, April 03, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has entered into a definitive share purchase agreement with an arm’s length vendor (the “Vendor”) dated April 1, 2025 to acquire a 100% interest in a pre-1954 charter company (the “Charter Company”) in Ontario, Canada (the “Acquisition”). The Corporation has agreed to purchase the Charter Company for $2,090,000, which will be paid using cash on hand (the “Purchase Price”). The Acquisition is expected to close on or about April 30, 2025, subject to satisfaction of customary closing conditions. No finder’s fee is payable in respect of the Acquisition.
Read more at globenewswire.com